FDA Gives Thumbs Up to Takeda’s Entyvio for Easier Crohn’s Disease Treatment!
FDA Gives Thumbs Up to Takeda’s Entyvio for Easier Crohn’s Disease Treatment! ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for Maintenance Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Exciting news for those suffering from Crohn’s Disease and Ulcerative Colitis! Takeda, a pharmaceutical company…